
Marlox Plus200 ml
Incepta Pharmaceuticals Ltd.
Magaldrate + Simethicone is an antacid-antiflatulent combination used for the short-term relief of gastrointestinal discomfort caused by excess stomach acid and trapped gas.
Magaldrate + Simethicone is an antacid-antiflatulent combination used for the short-term relief of gastrointestinal discomfort caused by excess stomach acid and trapped gas.
Magaldrate + Simethicone provides symptomatic relief only; it does not treat the underlying cause of acid-related disease and is not a substitute for evaluation and treatment of persistent or severe symptoms.
| Formulation | Dose | Frequency |
|---|---|---|
| Chewable tablet | 1–2 tablets, chewed thoroughly | 20–60 minutes after meals and at bedtime, or as symptoms occur |
| Oral suspension | 1–2 teaspoonfuls (5–10 mL) | 20–60 minutes after meals and at bedtime, or as symptoms occur |
Do not exceed the maximum dose stated on the product label (commonly up to 4 tablets or 4 teaspoonfuls in 24 hours, unless a physician advises otherwise). Do not use continuously for more than 2 weeks without consulting a physician.
Safety and efficacy of Magaldrate + Simethicone in children have not been well established; pediatric use should only be under a physician's guidance and supervision.
Use with caution and under medical supervision in patients with reduced kidney function; see Precautions and Warnings.
Chewable tablets should be chewed thoroughly before swallowing. The oral suspension should be shaken well before use and may be taken directly or followed by a small amount of water. Other oral medicines should be spaced at least 2 hours apart from Magaldrate + Simethicone (see Interactions).
Magaldrate + Simethicone is generally well tolerated when used as directed. Gastrointestinal effects are the most commonly reported and are usually related to the magnesium/aluminum balance:
Rarely, and mainly with prolonged high-dose use or in patients with renal impairment, symptoms of magnesium or aluminum accumulation (e.g., hypermagnesemia) may occur; see Precautions and Warnings.
Magaldrate + Simethicone is contraindicated in patients with known hypersensitivity to magaldrate, simethicone, or any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.